Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function Vitiello BChild Adolesc Psychiatr Clin N Am 2008[Apr]; 17 (2): 459-74, xiThe effects of stimulant medications and atomoxetine on physical growth and on cardiovascular function are reviewed in light of the most recent data, with attention to clinical implications and research needs. Although these medications have a favorable benefit/risk profile and do not induce clinically significant changes in growth or cardiovascular function in the majority of cases, careful patient monitoring is needed to identify individuals at risk for negative outcomes. More research is needed to elucidate the mechanism of growth suppression to estimate better the risk for rare but life-threatening events and test the effectiveness of monitoring procedures.|Adolescent[MESH]|Adrenergic Uptake Inhibitors/adverse effects/therapeutic use[MESH]|Appetite/drug effects[MESH]|Atomoxetine Hydrochloride[MESH]|Attention Deficit Disorder with Hyperactivity/*drug therapy[MESH]|Blood Pressure/*drug effects[MESH]|Body Height/*drug effects[MESH]|Central Nervous System Stimulants/*adverse effects/therapeutic use[MESH]|Child[MESH]|Child, Preschool[MESH]|Controlled Clinical Trials as Topic[MESH]|Death, Sudden, Cardiac/*etiology[MESH]|Electrocardiography/*drug effects[MESH]|Heart Rate/*drug effects[MESH]|Humans[MESH]|Long-Term Care[MESH]|Methylphenidate/adverse effects/therapeutic use[MESH]|Propylamines[MESH]|Risk Factors[MESH] |